|
Academic Year: | 2012/3 |
Owning Department/School: | School of Management |
Credits: | 6 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
Semester 2 |
Assessment: | CW 20%, EX 80% |
Supplementary Assessment: | Like-for-like reassessment (where allowed by programme regulations) |
Requisites: | Before taking this unit you must take MN30170 or take MN50319 and in taking this unit you cannot take MN50321 |
Description: | Aims: The aim of the course is to give the student an understanding of the increased range of financial issues that arise when companies operate across international borders. Learning Outcomes: The student will be able to analyse a financial environment and assess risk faced by multinational companies. They will be able to reach a decision as to how to formulate a company policy to manage them. Skills: Intellectual Analytical skills; defining the exposures facing an organisation be they foreign exchange, interest rate or systemic. Analysing the financial consequences of the various approaches to hedging and managing these risks. T & A Advocacy; being able to support an argument based on the facts and a reasonable personal interpretation of the facts and personal risk preferences. T&F&A Professional/practical; learning about markets (domestic and international), instruments and company and bank practices. T&A Key skills; analytical, numerical, organisational. T&A&F Content: The course will focus on a careful analysis of fundamental differences between domestic and international financial management. In particular, it will cover such issues as: (i) corporate governance in cross border operations (ii) foreign exchange theory (determination and forecasting) (iii) foreign exchange markets and derivatives (iv) foreign currency exposure (v) financing objectives, methods and instruments (vi) foreign investment decision-making principles. |
Programme availability: |
MN50182 is Compulsory on the following programmes:School of Management
MN50182 is Optional on the following programmes:Department of Economics
|